Span Divergent's Q2 FY24-25 financial report shows positive signs for the company's growth

Span Divergent, a microcap company in the medical equipment/supplies/accessories industry, recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Sell' call by MarketsMOJO.

According to the financial report, Span Divergent's performance in Q2 FY24-25 has remained flat, with no significant changes in the last three months. However, the company has shown some positive aspects in its financials.

One of the highlights is the Debtors Turnover Ratio, which has been the highest in the last five half-yearly periods at 8.54 times. This indicates that the company has been able to collect payments from its debtors at a faster rate.

Another positive aspect is the Profit After Tax (PAT) for the nine-month period, which stands at Rs 0.95 Cr. This is higher than the preceding 12-month period ended September 2024, which was at Rs -0.45 Cr. This shows that the company has already surpassed its sales from the previous year in just nine months.

While the company's financial performance may not be impressive, these factors show that Span Divergent is making progress in certain areas. Investors should keep an eye on the company's future financial reports to see if this trend continues.